100XBIO develops single-cell and spatial biology technologies enabling high-resolution cellular analysis for research and drug discovery.
100XBIO has raised $20K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2025.
100XBIO is headquartered in Woburn, United States.
100XBIO develops single-cell and spatial biology technologies enabling high-resolution cellular analysis for research and drug discovery.
100XBIO is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"100XBIO — Funding & Investors." VCBacked, December 5, 2025, https://www.vcbacked.co/company/100xbio. Accessed August 13, 2026.
VCBacked. (2025). 100XBIO — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/100xbio
{{cite web |title=100XBIO — Funding & Investors |url=https://www.vcbacked.co/company/100xbio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated